Expression of Kunitz protease inhibitor-containing forms of amyloid β- protein precursor within vascular thrombi

Circulation

Volumn 94, Issue 11, 1996, Pages 2728-2734

  Lang, Irene M ^a,b   Mose, Kenneth M ^a   Schleef, Raymond R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

amyloid; endothelium; polymerase chain reaction; pulmonary heart disease; thrombosis

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APROTININ;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS; THROMBOSIS;

EID: 0029800653     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2728     Document Type: Article

References (50)

1. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990;81:1735-1743.
2. Rich S, Levitsky S, Brundage B. Pulmonary hypertension from chronic pulmonary thromboembolism. Ann Intern Med. 1988;108:425-434.
3. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103:685-692.
4. Benotti JR, Ockene IS, Alpen JS, Dalen JE. The clinical profile of unresolved pulmonary embolism. Chest. 1983;84:669-678.
5. Daily PO, Dembitsky WP, Peterson KL, Moser KM. Modification of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Thorac Cardiovasc Surg. 1987;93:221-233.
6. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Tarazi RY, Moser KM. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg. 1993;116:116-127.
7. Lang IM, Marsh JJ, Olman MA, Moser KM, Loskutoff DJ, Schleef RR. Expression of type l plasminogen activator inhibitor in chronic pulmonary thromboemboli. Circulation. 1994;89:2715-2721.
8. Eitzman DT, McCoy RD, Fay WP, Shen T. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 1996;97:232-237.
9. Van Nostrand WE, Wagner SL, Farrow JS, Cunningham DD. Immunopurification and protease inhibitory properties of protease nexin-2/amyloid β-protein precursor. J Biol Chem. 1990;265:9591-9594.
10. Smith RP, Higuchi DA, Broze GJ Jr. Platelet coagulation Factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science. 1990;248:1126-1128.
11. Schmaier AH, Dahl LD, Rozemuller AJM, Roos RAC, Wagner SL. Chung R, Van Nostrand WE. Protease nexin-2/amyloid β protein precursor: a tight-binding inhibitor of coagulation factor IXa. J Clin Invest. 1993;92:2540-2545.
12. Schmaier AH, Dahl LD, Hasan AA, Cines DB, Bauer KA, Van Nostrand WE. Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes. Biochem. 1995;34:1171-1178.
13. Marotta CA, Majocha RE, Tate B. Molecular and cellular biology of Alzheimer amyloid. J Mol Neurosci. 1992;3:111-125.
14. Wisniewski HM, Wegiel J. Alzheimer's disease neuropathology: current status of interpretation of lesion development. Ann N Y Acad Sci. 1992;673:270-284.
15. Selkoe DJ. Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol. 1994;4:708-716.
16. Selkoe DJ. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol. 1994;10:373-403.
17. Coria F, Moreno A, Torres A, Ahmad I, Ghiso J. Distribution of Alzheimer's disease amyloid protein precursor in normal human and rat nervous system. Neuropathol Appl Neurobiol. 1992;18:27-35.
18. Kim T, Choi BH, Choe W, Kim RC, Van Nostrand WE, Wagner S, Cunningham D. Expression of protease nexin-II in human dorsal root ganglia: a correlative immunocytochemical and in situ hybridization study. Mol Chem Neuropathol. 1992;16:225-239.
19. LeBlanc AC, Chen HY, Autilio GL, Gambetti L. Differential APP gene expression in rat cerebral cortex, meninges, and primary astroglial, microglial and neuronal cultures. FEBS Lett. 1991;292:171-178.
20. Sola C, Mengod G, Ghetti B, Palacios JM, Triarhou LC. Regional distribution of the alternatively spliced isoforms of beta APP RNA transcript in the brain of normal, heterozygous and homozygous weaver mutant mice as revealed by in situ hybridization histochemistry. Mol Brain Res. 1993;17:340-346.
21. Tate-Ostroff OB, Majocha RE, Marotta CA. Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. Proc Natl Acad Sci U S A. 1989;86:745-749.
22. Yamada T, Araki E, Izumi R, Goto I, Sasaki H, Sakaki Y. Expression of Alzheimer amyloid beta-protein precursor gene in neuronal cells. Gerontolngy. 1991;1:24-30.
23. Wolozin B, Bacic M, Merrill MJ, Lesch KP, Chen C, Lebovics RS, Sunderland T. Differential expression of carboxyl terminal derivatives of amyloid precursor protein among cell lines. J Neurosci Res. 1992;33:163-169.
24. Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial. neuronal and glial cells: modulation by interleukin-1. Mol Brain Rex. 1992;16:128-134.
25. Allen JS, Murphy CM Jr, Eng LF, Stultz KE, Davies HD, Pickford LB, Tinklenberg JR, Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells. Neurosci Lett. 1991;132:109-112.
26. Buckland P, Tidmarsh S, Spurlock G, Kaiser F, Yates M, O'Mahony G, McGuffin P. Amyloid precursor protein mRNA levels in the mononuclear blood cells of Alzheimer's and Down's patients. Mol Brain Res. 1993:18:316-320.
27. Bauer J, Konig G, Strauss S, Jonas U, Ganter U, Weidemann A, Monning U, Masters CL, Volk B, Berger M. In-vitro matured human macrophages express Alzheimer's beta A4-aniyloid precursor protein indicating synthesis in microglial cells. FEBS Lett. 1991;282:335-340.
28. Gardella JE, Gorgone GA, Newman P, Grangione B, Gorevic PD. Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megakaryocytes. Neurosci Lett. 1992;138:229-232.
29. Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyreuther K, Masters CL. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem. 1990;265:15977-15983.
30. Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neural. 1991;30:686-693.
31. Schmechel DE, Goldgaber D, Burkhart DS, Gilbert JR, Gajdusek DC, Roses AD. Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimcr disease. Alzheimer Dis Assoc Disord. 1988;2:96-111.
32. Joachim CL, Mori H, Selkoe DJ. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease. Nature. 1989;341:226-230.
33. Tamaoka A, Kalaria RN, Lieberburg I, Selkoe DJ. Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels. Proc Natl Acad Sci U S A. 1992;89:1345-1349.
34. Goldgaber D, Harris- HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A. 1989;86:7606-7610.
35. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, dandy SE, Greengard P, Cholinergic agonists and interleukin 1 reg ulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci U S A. 1992:89:10075-10078.
36. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 1992;357:500-503.
37. Ciallella JR, Rangnekar VV, McGillis JP. Heat shock alters Alzheimer's beta amyloid precursor protein expression in human endothelial cells. J Neurosci Res. 1994;37:769-776.
38. Van Nostrand WE, Schmaler AH, Farrow JS, Cunningham DD. Protease nexin-II (amyloid β-protein precursor): a platelet α-granule protein. Science. 1990;248:745-748.
39. Schlossmacher MG, Ostaszewski BL, Hecker LI, Celi A, Haass C, Chin D, Lieberburg I, Furie BC, Furie B, Selkoe D.J. Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging. 1992;13:421-434.
40. Li Q-X, Berndt MC, Bush AI, Rumble B, Mackenzie I, Friedhuber A, Beyreuther K, Masters CL. Membrane-associated forms of the βA4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. Blood. 1994;84:133-142.
41. Nomura S, Komiyama Y, Miyake T, Miyazaki Y, Kido H, Suzuki M, Kagawa H, Yanabu M, Takahashi H, Fukuhara S, Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost. 1994;72:519-522.
42. Van Nostrand WE, Schmaier AH, Wagner SL. Potential role of protease nexin-2/amyloid β-protein precursor as a cerebral anticoagulant. Ann N Y Acad Sci. 1994;674:243-252.
43. Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Platelet protease nexin-2/amyloid beta-protein precursor: possible pathologic and physiologic functions. Ann N Y Acad Sci. 1991;640:140-144.
44. Kriett JM, Smith CM, Hayden AM, Robert R. Parthasaralhy R, Kapelanski DP, Jamieson SW. Lung transplantation without the use of antilymphocyte antibody preparations. J Heart Lung Transplant. 1994;13:915-923.
45. Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG. Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron. 1990;4:253-267.
46. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988;331:525-527.
47. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ. Interleukin 1 (IL-1) and tumor necrosis factor (TNF) activation of vascular endothelium: effects on plasminogen activator inhibitor (PAI-1) and tissue type plasminogen activator (tPA). J Biol Chem. 1988;263:5797-5803.
48. Broze GJ Jr. Tissue factor pathway inhibitor. Thromb Haemost. 1995;74:90-93.
49. Davis-Salinas J, Saporito-Irwin SM, Donovan FM, Cunningham DD, Van Nostrand WE. Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid β-protein precursor. J Biol Chem. 1994;269:22623-22627.
50. Wirak DO, Bayney R, Kundel CA, Lee A, Scangos GA, Trapp BD, Unterbeck AJ. Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice. EMBO J. 1991;10:289-296.